December 07, 2010 09:08 ET

US Biotech Market Expected to Grow 7% Annually Through 2013

ROCKVILLE, MD--(Marketwire - December 7, 2010) - has announced the addition of RNCOS's new report, "US Biotech Market Analysis," to their collection of Agriculture GMO market reports. For more information, visit

Due to rising instances of innovations in information technology, world-class healthcare infrastructure, and active participation by private players, the U.S. biotech industry has stupendously grown during the past few years. In 2009, the industry reached the mark of US$ 72 Billion and is expected to grow at the CAGR of 7% to reach approx US$ 95 Billion by 2013. Despite recession, the industry has impressively witnessed key developments in terms of financing by market players and private institutions. The government has outlined various policies and measures that are addressed towards further strengthening the biotech sector and its sub-sectors.

According to the new research report, "US Biotech Market Analysis," future growth in the US biotech sector will be boosted by increasing application usage in the areas of crop biotechnology, bio-pharmaceuticals, clinical trial market, biotech-products, and bioscience development. Moreover, the strategic decisions, which are to be implemented in various states, will further fuel the US biotech industry. In this regard, we have done an extensive research and analysis of the US biotech market together and its segments.

The research has found that biotech funding has been a major source of growth in the US biotech industry as venture capital and financing by other sources continue to provide the momentum. The structure of financing has been strengthening for the past few years with IPOs, FPOs, public and private sector and venture funds constituting significant part to the industry developments. Rising focus of companies towards drug development, increasing coverage of various diseases, and significant market potential are some of the prominent factors that have boosted investment proportion in recent years. The future outlook of the US biotech sector is positive and vibrant as a good amount of investments are expected for the promotion of research and entrepreneurship development in near future.

The report provides comprehensive information, prudent analysis, and reliable statistics of the US biotech market. The report has covered key market developments; current industry trends, and competitive landscape to enable clients understand the market structure and its progress in coming years. Use of effective techniques and methods for future outlook has further augmented the reliability with respect to projections.

For more information, visit

Contact Information